0001209191-22-006286.txt : 20220202
0001209191-22-006286.hdr.sgml : 20220202
20220202135833
ACCESSION NUMBER: 0001209191-22-006286
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220131
FILED AS OF DATE: 20220202
DATE AS OF CHANGE: 20220202
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Geuijen Cecile A W
CENTRAL INDEX KEY: 0001859721
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37773
FILM NUMBER: 22582772
MAIL ADDRESS:
STREET 1: C/O MERUS N.V.
STREET 2: YALELAAN 62
CITY: UTRECHT
STATE: P7
ZIP: 3584CM
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Merus N.V.
CENTRAL INDEX KEY: 0001651311
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: P7
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: YALELAAN 62
CITY: 3584 CM UTRECHT
STATE: P7
ZIP: 3584 CM
BUSINESS PHONE: 31 030 253 8800
MAIL ADDRESS:
STREET 1: YALELAAN 62
CITY: 3584 CM UTRECHT
STATE: P7
ZIP: 3584 CM
FORMER COMPANY:
FORMER CONFORMED NAME: Merus B.V.
DATE OF NAME CHANGE: 20150819
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-01-31
0
0001651311
Merus N.V.
MRUS
0001859721
Geuijen Cecile A W
C/O MERUS N.V.
YALELAAN 62
UTRECHT
P7
3584 CM
NETHERLANDS
0
1
0
0
SVP & Chief Scientific Officer
Share Option (right to buy)
24.61
2022-01-31
4
A
0
55000
0.00
A
2032-01-31
Common Shares
55000
55000
D
Options vest over a four-year period from January 1, 2022. 25% vest on January 1, 2023 and in 36 equal monthly installments thereafter.
/s/ Peter Silverman as attorney-in-fact
2022-02-02